Works matching IS 00283835 AND DT 2020 AND VI 110 AND IP 1/2


Results: 17
    1

    Front & Back Matter.

    Published in:
    Neuroendocrinology, 2020, v. 110, n. 1/2, p. 1, doi. 10.1159/000505789
    Publication type:
    Article
    2

    Authors' Response to the Letter by Lamarca et al. Entitled "Temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration" Regarding "Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms"

    Published in:
    2020
    By:
    • Chatzellis, Eleftherios;
    • Daskalakis, Kosmas;
    • Angelousi, Anna;
    • Tsoli, Marina;
    • Alexandraki, Krystallenia I.;
    • Wachula, Ewa;
    • Meirovitz, Amichay;
    • Maimon, Ofra;
    • Grozinsky-Glasberg, Simona;
    • Gross, David;
    • Kos-Kudła, Beata;
    • Koumarianou, Anna;
    • Kaltsas, Gregory
    Publication type:
    Letter
    3
    4
    5
    6
    7
    8

    A New Generation Somatostatin-Dopamine Analogue Exerts Potent Antitumoral Actions on Pituitary Neuroendocrine Tumor Cells.

    Published in:
    Neuroendocrinology, 2020, v. 110, n. 1/2, p. 70, doi. 10.1159/000500812
    By:
    • Vázquez-Borrego, Mari C.;
    • L-López, Fernando;
    • Gálvez-Moreno, María A.;
    • Fuentes-Fayos, Antonio C.;
    • Venegas-Moreno, Eva;
    • Herrera-Martínez, Aura D.;
    • Blanco-Acevedo, Cristóbal;
    • Solivera, Juan;
    • Landsman, Tanya;
    • Gahete, Manuel D.;
    • Soto-Moreno, Alfonso;
    • Culler, Michael D.;
    • Castaño, Justo P.;
    • Luque, Raúl M.
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17